| US12043650B2 | 23 July 2024 | Grant | US18133893 | Methods and compositions for modification of a cystic fibrosis transmembrane conductance regulator (CFTR) gene | Sangamo Therapeutics Inc |
|---|
| US11981967B2 | 14 May 2024 | Grant | US16858489 | Engineering aav | Sangamo Therapeutics Inc |
|---|
| US11981739B2 | 14 May 2024 | Grant | US17047232 | Chimeric antigen receptor specific for interleukin-23 receptor | Sangamo Therapeutics France SAS |
|---|
| US11920169B2 | 5 March 2024 | Grant | US16906845 | Compositions for linking dna-binding domains and cleavage domains | Sangamo Therapeutics Inc |
|---|
| US11898158B2 | 13 February 2024 | Grant | US16842139 | Methods and compositions for the treatment of lysosomal storage diseases | Sangamo Therapeutics Inc |
|---|